CDK2 (fosfo Thr160) Antilichaam

Involved in the control of the cell cycle. Interacts with cyclins A, B1, B3, D, or E. Activity of CDK2 is maximal during S phase and G2.

1017

P24941

NP_001789.2

Human, Mouse, Rat

CDK2 (Phospho-Thr160) antibody was raised against a peptide sequence around phosphorylation site of threonine 160 (T-Y-T (p) -H-E) derived from Human CDK2.

Unconjugated

Primary Antibodies

Phospho-Specific, Apoptosis, Cancer, Cell Cycle

Antibodies were purified by affinity-chromatography using epitope-specific phosphopeptide. Non-phospho specific antibodies were removed by chromatogramphy using non-phosphopeptide.

1 mg/mL

Antibody supplied in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.

Phospho-Specific

Blue Ice

Store antibody at -20˚ C for up to one year.

34 kDa

This antibody detects endogenous level of CDK2 only when phosphorylated at threonine 160.

Western Blot: 1:500~1:1000, Immunohistochemistry: 1:50~1:100

CDK2

Cyclin-dependent kinase 2

Homo sapiens

Ukomadu C, et al. (2003) J Biol Chem; 278 (7) : 4840-6. Morris MC, et al. (2002) J Biol Chem; 277 (26) : 23847-53. Brown NR, et al. (1999) J Biol Chem; 274 (13) : 8746-56. Liu Y, et al. (2004) J Biol Chem; 279 (6) : 4507-14.

CDKN2, p33 (CDK2), JNKK1, MEK4, MKK4, PRKMK4, SEK1, SERK1, SKK1, kinase Cdk2, p33 protein kinase

WB, IHC

16936528

Liquid